Development of glycan-based antimicrobial therapies

• Unité de recherche: INNOSUISSE
• Numéro de projet: 104.462.1 IP-LS
• Titre du projet anglais: Development of glycan-based antimicrobial therapies

Description succincte (Allemand)

Development of glycan-based antimicrobial therapies

Description succincte (Anglais)

Development of glycan-based antimicrobial therapies

Résumé des résultats (Abstract) (Allemand)

Antimicrobial resistance is reaching a global crisis and the WHO considers it a major health threat. Alternative therapies for infection are urgently needed, therefore we have developed a novel drug class targeting a range of pathogens while retaining natural flora to restore microbiome homeostasis.

Résumé des résultats (Abstract) (Anglais)

Antimicrobial resistance is reaching a global crisis and the WHO considers it a major health threat. Alternative therapies for infection are urgently needed, therefore we have developed a novel drug class targeting a range of pathogens while retaining natural flora to restore microbiome homeostasis.